TC BioPharm Limited Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative)										1 Months Ended
SUBSEQUENT EVENTS (Details Narrative)	Mar. 12, 2024 USD ($) shares	Mar. 12, 2024 GBP (£) shares	Mar. 08, 2024 USD ($) shares	Mar. 07, 2024 $ / shares shares	Feb. 29, 2024 $ / shares shares	Aug. 30, 2023 USD ($)	Aug. 30, 2023 GBP (£)	Jun. 08, 2022 shares	Feb. 10, 2022 shares	Jan. 31, 2024 shares	Mar. 08, 2024 £ / shares	Dec. 31, 2023 £ / shares	Apr. 03, 2023 $ / shares	Dec. 31, 2022 £ / shares	Nov. 18, 2022 £ / shares	Aug. 09, 2022 shares
Subsequent Event [Line Items]
Balance, shares								230,000	63,280
Common stock, par value \| (per share)												£ 0.0001	$ 0.30	£ 0.0001	£ 0.0001
Number of warrants outstanding																233,560
Proceeds from warrants exercise						$ 2,800,000	£ 2,200,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Balance, shares	623,750	623,750
Subsequent Event [Member] \| Series D Warrants [Member]
Subsequent Event [Line Items]
Number of warrants outstanding	12,475,000	12,475,000
Proceeds from warrants exercise	$ 1,263,000	£ 986,398
Subsequent Event [Member] \| Bryan Kobel [Member]
Subsequent Event [Line Items]
Options grants shares				153,000
Balance, shares				3,060,000
Unpaid contractual pension benefits \| $			$ 66,000
Convert aggregate amount \| $			$ 24,760
Convert ordinary shares			476,153
Common stock, par value \| £ / shares											£ 0.0001
Exercise price \| $ / shares				$ 2.00
Subsequent Event [Member] \| Non Employee Director [Member] \| Twenty Twenty One Shares Option Scheme [Member]
Subsequent Event [Line Items]
Options grants shares					41,760
Balance, shares					835,200
Exercise price \| $ / shares					$ 1.09
Subsequent Event [Member] \| Chief Financial Officer [Member] \| Twenty Twenty One Shares Option Scheme [Member]
Subsequent Event [Line Items]
Options grants shares					177,122
Balance, shares					3,542,440
Exercise price \| $ / shares					$ 1.09
Subsequent Event [Member] \| Chief Executive Officer [Member] \| Twenty Twenty One Shares Option Scheme [Member]
Subsequent Event [Line Items]
Options grants shares					381,606
Balance, shares					7,632,120
Exercise price \| $ / shares					$ 1.09
Subsequent Event [Member] \| Prefunded Warrant [Member]
Subsequent Event [Line Items]
Options grants shares										1,398,000